These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
88 related articles for article (PubMed ID: 12827450)
1. Point mutations in exon 1 of the NR4A2 gene are not a major cause of familial Parkinson's disease. Zimprich A; Asmus F; Leitner P; Castro M; Bereznai B; Homann N; Ott E; Rutgers AW; Wieditz G; Trenkwalder C; Gasser T Neurogenetics; 2003 Aug; 4(4):219-20. PubMed ID: 12827450 [No Abstract] [Full Text] [Related]
2. Mutations in NR4A2 associated with familial Parkinson disease. Le WD; Xu P; Jankovic J; Jiang H; Appel SH; Smith RG; Vassilatis DK Nat Genet; 2003 Jan; 33(1):85-9. PubMed ID: 12496759 [TBL] [Abstract][Full Text] [Related]
3. Nurr1 mutational screen in Parkinson's disease. Tan EK; Chung H; Chandran VR; Tan C; Shen H; Yew K; Pavanni R; Puvan KA; Wong MC; Teoh ML; Yih Y; Zhao Y Mov Disord; 2004 Dec; 19(12):1503-5. PubMed ID: 15390059 [TBL] [Abstract][Full Text] [Related]
5. Absence of previously reported variants in the SCNA (G88C and G209A), NR4A2 (T291D and T245G) and the DJ-1 (T497C) genes in familial Parkinson's disease from the GenePD study. Karamohamed S; Golbe LI; Mark MH; Lazzarini AM; Suchowersky O; Labelle N; Guttman M; Currie LJ; Wooten GF; Stacy M; Saint-Hilaire M; Feldman RG; Liu J; Shoemaker CM; Wilk JB; DeStefano AL; Latourelle JC; Xu G; Watts R; Growdon J; Lew M; Waters C; Vieregge P; Pramstaller PP; Klein C; Racette BA; Perlmutter JS; Parsian A; Singer C; Montgomery E; Baker K; Gusella JF; Herbert A; Myers RH Mov Disord; 2005 Sep; 20(9):1188-91. PubMed ID: 15966003 [TBL] [Abstract][Full Text] [Related]
6. Translated mutation in the Nurr1 gene as a cause for Parkinson's disease. Grimes DA; Han F; Panisset M; Racacho L; Xiao F; Zou R; Westaff K; Bulman DE Mov Disord; 2006 Jul; 21(7):906-9. PubMed ID: 16532445 [TBL] [Abstract][Full Text] [Related]
7. Extended mutation analysis and association studies of Nurr1 (NR4A2) in Parkinson disease. Hering R; Petrovic S; Mietz EM; Holzmann C; Berg D; Bauer P; Woitalla D; Müller T; Berger K; Krüger R; Riess O Neurology; 2004 Apr; 62(7):1231-2. PubMed ID: 15079038 [No Abstract] [Full Text] [Related]
17. Nurr1 in Parkinson's disease and related disorders. Chu Y; Le W; Kompoliti K; Jankovic J; Mufson EJ; Kordower JH J Comp Neurol; 2006 Jan; 494(3):495-514. PubMed ID: 16320253 [TBL] [Abstract][Full Text] [Related]
18. NR4A2 and schizophrenia: lack of association in a Portuguese/Brazilian study. Ruano D; Macedo A; Dourado A; Soares MJ; Valente J; Coelho I; Santos V; Azevedo MH; Goodman A; Hutz MH; Gama C; Lobato MI; Belmonte-de-Abreu P; Palha JA Am J Med Genet B Neuropsychiatr Genet; 2004 Jul; 128B(1):41-5. PubMed ID: 15211629 [TBL] [Abstract][Full Text] [Related]
19. The BCL2 code to dopaminergic development and Parkinson's disease. van der Heide LP; Smidt MP Trends Mol Med; 2013 Apr; 19(4):211-6. PubMed ID: 23523055 [TBL] [Abstract][Full Text] [Related]
20. [The research advance of nuclear receptor Nurr1]. Lai YL; Xie ZP Sheng Li Ke Xue Jin Zhan; 2004 Apr; 35(2):177-80. PubMed ID: 15285431 [No Abstract] [Full Text] [Related] [Next] [New Search]